Showing results (101-110 of 151) with videos related to
Sort By:
Pageof 16
Clinical and Translational Science|September 28, 2021
Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2)Solange Peters, Peter R Galle, Coen A Bernaards, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 16, 2003
Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial developmentXinli Zhang, Dale Carpenter, Nobuyuki Bokui, et al.North Carolina Medical Journal|July 11, 2022
Temporal Changes in Treatment Patterns for Rural and Urban Patients With Early-Stage Non-Small Cell Lung CancerJoshua Herb, Tzy-Mey Kuo, Vaibhav Kumar, et al.Cancer Chemotherapy and Pharmacology|June 3, 2015
Pharmacokinetic drug-drug interaction assessment of peptibody trebananib in combination with chemotherapiesBenjamin Wu, Rebeca Melara, Erik Rasmussen, et al.Bioresearch Open Access|June 30, 2016
Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone FormationJustine Tanjaya, Yulong Zhang, Soonchul Lee, et al.Military Medicine|September 8, 2012
Prevalence of DSM-IV major depression among U.S. military personnel: meta-analysis and simulationAnne M Gadermann, Charles C Engel, James A Naifeh, et al.Clinical Pharmacokinetics|August 13, 2016
Pharmacokinetics, Biotransformation, and Excretion of [14C]Etelcalcetide (AMG 416) Following a Single Microtracer Intravenous Dose in Patients with Chronic Kidney Disease on HemodialysisRaju Subramanian, Xiaochun Zhu, M Benjamin Hock, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 15, 2014
A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine modelYuan Lin, Jie Luo, Weichao Eric Zhu, et al.Nature Biotechnology|April 13, 2004
Adipose-derived adult stromal cells heal critical-size mouse calvarial defectsCatherine M Cowan, Yun-Ying Shi, Oliver O Aalami, et al.Clinical Breast Cancer|November 14, 2018
Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast CancerPeter A Kaufman, Hans Wildiers, Gilles Freyer, et al.Pageof 16